ADVANCED OVARIAN CARCINOMA
Clinical trials for ADVANCED OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Ovarian cancer drug trial tests DNA changes before surgery
Knowledge-focused OngoingThis early-phase trial is testing how the drug adavosertib affects the DNA of tumor cells in 38 people with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to learn how the drug changes the cancer's DNA, which may help doctors plan bet…
Matched conditions: ADVANCED OVARIAN CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC